Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Thorne

Showing results (381-390 of 405) with videos related to

Pageof 41
Sort By:
Ocular Immunology and Inflammation|February 12, 2025
Incidence and Outcome of Cataract in Eyes with Scleritis and EpiscleritisMichelle J Sun, Bernard A Rosner, Craig W Newcomb, et al.
Journal of the International AIDS Society|April 7, 2016
A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohortsKeri N Althoff, Peter F Rebeiro, David B Hanna, et al.
Annals of Epidemiology|December 12, 2018
Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimatesHeather Bradley, Keri N Althoff, Kate Buchacz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining CancersMeredith S Shiels, Keri N Althoff, Ruth M Pfeiffer, et al.
Plos One|November 22, 2013
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009David B Hanna, Kate Buchacz, Kelly A Gebo, et al.
Journal of the American Heart Association|September 21, 2022
Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus CoinfectionRaynell Lang, Elizabeth Humes, Brenna Hogan, et al.
Ocular Immunology and Inflammation|February 5, 2025
Incidence and Outcomes of Cataract in Eyes with Ocular Cicatricial PemphigoidPichaporn Artornsombudh, Maxwell Pistilli, Craig W Newcomb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Annals of Internal Medicine|September 5, 2012
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008Keri N Althoff, Kate Buchacz, H Irene Hall, et al.
Ophthalmology|November 6, 2020
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisEric B Suhler, Glenn J Jaffe, Eric Fortin, et al.
Pageof 41

Showing results (381-390 of 405) with videos related to

Sort By:
Pageof 41
Ocular Immunology and Inflammation|February 12, 2025
Incidence and Outcome of Cataract in Eyes with Scleritis and EpiscleritisMichelle J Sun, Bernard A Rosner, Craig W Newcomb, et al.
Journal of the International AIDS Society|April 7, 2016
A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohortsKeri N Althoff, Peter F Rebeiro, David B Hanna, et al.
Annals of Epidemiology|December 12, 2018
Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimatesHeather Bradley, Keri N Althoff, Kate Buchacz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining CancersMeredith S Shiels, Keri N Althoff, Ruth M Pfeiffer, et al.
Plos One|November 22, 2013
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009David B Hanna, Kate Buchacz, Kelly A Gebo, et al.
Journal of the American Heart Association|September 21, 2022
Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus CoinfectionRaynell Lang, Elizabeth Humes, Brenna Hogan, et al.
Ocular Immunology and Inflammation|February 5, 2025
Incidence and Outcomes of Cataract in Eyes with Ocular Cicatricial PemphigoidPichaporn Artornsombudh, Maxwell Pistilli, Craig W Newcomb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Annals of Internal Medicine|September 5, 2012
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008Keri N Althoff, Kate Buchacz, H Irene Hall, et al.
Ophthalmology|November 6, 2020
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisEric B Suhler, Glenn J Jaffe, Eric Fortin, et al.
Pageof 41